Latest Strategic Planning News

Renergen Limited’s shares will be suspended from ASX trading on December 31, 2025, marking a key step in its acquisition by ASP Isotopes Inc. This suspension follows the formal implementation of a scheme of arrangement agreed earlier this month.

Elixir Energy has been granted a 15-year retention license over its entire ATP2044 permit in Queensland’s Taroom Trough, securing 1,362 BCFe of 2C Contingent Gas Resources confirmed by the Daydream-2 well.

Rox Resources has completed a $200 million capital raise, including a $134 million second tranche placement, to fund development of its Youanmi Gold Project in Western Australia.

Rox Resources has strategically purchased gold put options covering half of its forecast production at the Youanmi Gold Project for FY2028, locking in price protection while retaining upside exposure.

HyTerra Limited has unveiled a comprehensive Strategic Plan targeting commercialisation of its Kansas hydrogen project and ambitious expansion across the US and globally. The plan leverages proprietary technology and recent drilling successes to position the company at the forefront of the emerging geologic hydrogen sector.

Rox Resources has increased its Share Purchase Plan to A$18 million following strong retail demand, complementing a $200 million institutional placement to fully fund the Youanmi Gold Project development.

Lunnon Metals has secured critical mining proposal approval for its Lady Herial gold deposit, moving the project closer to production under a binding ore purchase deal with St Ives Gold Mining.

Cue Energy Resources and partners have signed a Letter of Intent with the Northern Territory’s Power and Water Corporation to kickstart a four-well drilling program at Mereenie and Palm Valley, aiming for gas supply contracts through 2034.

Future Metals NL has completed strategic planning that enhances its flagship Panton PGM Project’s value, driven by a 35% rise in platinum group metal prices and expanded exploration programs. The company is also advancing infrastructure options and strengthening its management team to accelerate development.

Biome Australia has initiated its first human clinical trial for the proprietary probiotic strain Lactobacillus plantarum BMB18, aiming to validate its benefits for digestive and mood-related symptoms.

Atomic Eagle Limited announces Phil Hoskins as new CEO following Daniel Major's unexpected non-start, spotlighting the Muntanga Uranium Project's substantial resource base.

Brightstar Resources has completed its acquisition of Aurumin Limited, converting Aurumin shares and options into Brightstar securities and prompting Aurumin’s imminent delisting from the ASX.